Pinealon (EDH Tripeptide): Khavinson Brain Aging Bioregulator Research Profile 2026

# Pinealon (EDH Tripeptide): Khavinson Brain Aging Bioregulator Research Profile 2026

Pinealon, also known as the EDH tripeptide (Glutamic acid-Aspartic acid-Histamine, or Glu-Asp-Arg depending on variant nomenclature), is a synthesized bioregulator developed by the Russian Khavinson Institute of Gerontology. This research profile explores Pinealon's proposed mechanism, research evidence, protocols, and sourcing in the 2026 research landscape.

What is Pinealon?

Chemical Composition & Classification

Pinealon is classified as:

• •Tripeptide — Three amino acid chain (simplified from natural pineal peptides)
• •Bioregulator — Synthetic peptide designed to modulate specific physiological pathways
• •Pineal-specific — Purported to target the pineal gland and circadian rhythm regulation
• •Khavinson development — Part of the Russian bioregulator peptide program launched in the 1980s

Molecular Background

The tripeptide sequence and exact amino acid composition varies in literature, with "EDH" being one common nomenclature. The compound is derived from research into the pineal gland's secretory products and designed to mimic or enhance endogenous pineal function.

The Khavinson Bioregulator Classification

What Are Bioregulators?

The Khavinson Institute developed a class of compounds called "geroprotectors" or bioregulators:

• •Designed to restore organ-specific physiological function
• •Shorter sequences than full proteins for easier synthesis and stability
• •Named after target organs (Epithalon for pineal, Cerluten for cerebral, etc.)
• •Proposed to work through gene expression modulation

Pinealon's Position in the Bioregulator Family

Compared to other Khavinson bioregulators:

• •Epithalon — Also pineal-targeted; longer history of research; focused on telomerase and aging
• •Semax — Cerebral/cognitive focus; broader research base
• •Cerluten — Cerebral vascular peptide; complements Pinealon for brain health
• •Thymalin — Immune-focused; different organ system

Pinealon is often positioned as complementary to Epithalon, targeting circadian and neuroprotective pathways.

Proposed Mechanism: Retinal/Cerebral Protection and Circadian Rhythm

The Pineal Gland & Circadian Biology

The pineal gland produces:

• •Melatonin — Sleep-wake cycle regulation
• •Pineal peptides — Endogenous bioregulators (proposed function)
• •Neuroendocrine signals — Seasonal and circadian inputs

Pinealon's proposed role is to:

1. Enhance pineal secretory function — Increase endogenous melatonin and pineal peptide production

2. Modulate circadian rhythm — Improve sleep architecture and circadian alignment

3. Neuroprotection — Antioxidant and anti-inflammatory effects in the retina and brain

4. Gene expression — Upregulate protective genes in neural tissue

Retinal Specificity

Some research suggests Pinealon may also:

• •Protect retinal cells — Against oxidative stress and age-related degeneration
• •Support visual circadian synchronization — Eyes are primary circadian pacemaker input
• •Improve glial function — Supporting cells in the nervous system

Melatonin Pathway Interaction

Pinealon's mechanism may involve:

• •Direct melatonin synthesis enhancement
• •GABA and serotonin pathway modulation (melatonin precursors)
• •Antioxidant synergy with melatonin
• •Circadian amplitude enhancement

Research Studies on Cognitive Aging, Neuroprotection & Circadian Rhythm

Key Research Findings

Pinealon research comes primarily from Russian institutes. Notable areas:

Circadian Rhythm & Sleep

• •Studies show Pinealon administration correlates with improved sleep quality metrics
• •Effect on circadian phase shifting in shift-work studies
• •References: Khavinson Institute publications (specific PMIDs to be verified in peer review)

Neuroprotection & Aging

• •In vitro studies suggest antioxidant effects in neural cells
• •Animal models show potential cognitive preservation
• •Proposed mechanism: mitochondrial function preservation

Retinal Health

• •Limited but growing research on retinal ganglion cell protection
• •Proposed benefit for age-related macular degeneration (early-stage research)

Study Quality Note

Most Pinealon research is published in Russian journals or proceedings. Western peer-reviewed literature is limited. This limits direct comparison with Western pharmaceutical standards.

Dosage Protocols Used in Research Settings

Typical Research Protocols

Based on literature and protocol reports:

• •Dose range: 5-10 mg per administration
• •Frequency: 1-2 times daily (morning and evening)
• •Duration: 10-30 day courses, with breaks between cycles
• •Route: Typically subcutaneous or intranasal in research
• •Cycle pattern: 10 days on, 5-10 days off

Protocol Variations

Circadian Optimization Protocol

• •Morning dose (5 mg) — Aligns with cortisol peak
• •Evening dose (5 mg) — Supports melatonin transition

Neuroprotection Protocol

• •Single daily dose (10 mg) — May maximize sustained protective effects

Combined Bioregulator Stack

• •Pinealon + Epithalon + Semax — Targeting multiple aging pathways

Comparison with Other Brain Bioregulators

Epithalon vs. Pinealon

Semax (Cognitive Peptide) vs. Pinealon

• •Semax: Broader cognitive benefits, more research; non-specific neuroprotection
• •Pinealon: Pineal/circadian-specific; may complement Semax

Cerluten (Cerebral Vascular) vs. Pinealon

• •Cerluten: Blood vessel and general cerebral health
• •Pinealon: Pineal gland-specific; circadian axis
• •Often used together in protocols

Safety Profile & Available Study Data

Reported Safety

From published research and user reports:

• •Low toxicity — Animal models show minimal adverse effects at research doses
• •No major side effects reported — In available literature
• •Mild transient effects — Occasional reports of vivid dreams or sleep adjustment during first week
• •Individual variation — Response varies; some report no noticeable effect

Contraindications (Proposed)

Based on mechanism and bioregulator class:

• •Pregnancy/breastfeeding — Limited safety data
• •Severe mood disorders — Melatonin pathway effects could theoretically interact
• •Certain medications — Potential interactions with sedatives or psychiatric medications

Long-Term Safety

Long-term safety data is limited due to the peptide's research-only status and limited Western clinical trials.

Storage, Reconstitution & Sourcing

Storage Requirements

• •Temperature: 2-8°C (refrigerate)
• •Light: Protect from light (amber vial)
• •Humidity: Keep desiccated
• •Shelf life: 12-24 months depending on formulation
• •Reconstitution: Typically provided as lyophilized powder; reconstitute with sterile saline

Reconstitution Protocol

1. Aseptic technique — Use sterile field and gloved hands

2. Sterile saline — Use 0.9% sodium chloride solution

3. Gentle mixing — Do not shake vigorously

4. Stability post-reconstitution — Typically 2-4 weeks refrigerated

Sourcing Challenges (2026)

• •Limited supplier base — Few Western suppliers stock Pinealon
• •Russian origins — Most suppliers based in Russia or Eastern Europe
• •Import variability — Subject to import regulations by country
• •Quality verification — Ensure supplier provides CoA (Certificate of Analysis)
• •Regulatory status: Research-use only; not approved for human use

Disclaimer

For Research Use Only. Pinealon is not approved for human use by the FDA, EMA, or most national medicines agencies. This research profile is educational and intended for researchers, scientists, and informed individuals studying peptide biology and gerontology. Never administer Pinealon or any research peptide to humans outside of approved clinical trials. This content does not constitute medical advice. Consult qualified healthcare professionals before considering any peptide-related substances.

Related Resources

• •Epithalon vs Pinealon Comparison
• •Khavinson Bioregulators Overview
• •Brain Aging & Neuroprotection Research
• •Circadian Biology & Melatonin Pathway